MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1021/acs.jmedchem.5c01193

Медицинская библиотека · Journal of medicinal chemistry · 2025

Novltex: A New Class of Antibiotics with Potent Activity against Multidrug-Resistant Bacterial Pathogens─Design, Synthesis, and Biological Evaluation.

Malkawi Esra, Parmar Anish, Das Sanjit, Newire Enas, Jones Charlotte M, Morrison Kate A, Karak Milandip, Blanc Frédéric, Harper Nicholas, Lakshminarayanan Rajamani, Poh Zhi Sheng, Verma Navin K, Unsworth Jennifer, Hughes Dallas E, Ling Losee Lucy, Cochrane Stephen A, Hope William, Singh Ishwar

СтатьяПеревод пока не подготовлен

Аннотация

Increasing spread of multidrug-resistant (MDR) bacteria demands antibiotics that combine potent activity with scalable synthesis. Novo29 (clovibactin) is promising but suffers from low yield (1%), dependence on costly and noncommercial d-hydroxy-asparagine (d-Hyn5), and lengthy syntheses. We report "Novltex", a novel class of antibiotic that fuses the Leu10-teixobactin macrocycle to the Novo29 N-terminus tail, replacing d-Hyn5 with inexpensive threonine. Our efficient synthesis delivers 30% yield with faster coupling cycles (∼10 min), enabling rapid and low-cost scale-up. A 16-member analogue library systematically probing amino-acid configuration identified analogue 4 (d-Leu2) as the initial lead, informing the rational design of analogue 12 (d-cyclohexylalanine2). Analogue 12 displays potent antibacterial activity (minimum inhibitory concentration (MIC) 0.12-0.5 μg/mL) against World Health Organization (WHO)-priority pathogens, including methicillin-resistant Staphylococcus aureus (MRSA) and Enterococcus faecium, surpassing several licensed antibiotics while maintaining an excellent safety profile. Lipid II-binding assays confirm the conservation of the parent mechanism. Novltex, therefore, offers a practical, high-yielding, and cost-efficient platform for the development of next-generation antibiotics targeting MDR infections.

Для цитирования: Malkawi Esra, Parmar Anish, Das Sanjit, Newire Enas, Jones Charlotte M, Morrison Kate A, Karak Milandip, Blanc Frédéric, Harper Nicholas, Lakshminarayanan Rajamani, Poh Zhi Sheng, Verma Navin K, Unsworth Jennifer, Hughes Dallas E, Ling Losee Lucy, Cochrane Stephen A, Hope William, Singh Ishwar. Novltex: A New Class of Antibiotics with Potent Activity against Multidrug-Resistant Bacterial Pathogens─Design, Synthesis, and Biological Evaluation.. Journal of medicinal chemistry. 2025. DOI: 10.1021/acs.jmedchem.5c01193.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.